Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valproic Acid in Combination With Concurrent Chemoradiotherapy Using Gemcitabine for Unresectable Locally Advanced Pancreatic Cancer

NCT01333631 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT01333631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01333631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valproic Acid in Combination With Concurrent Chemoradiotherapy Using Gemcitabine for Unresectable Locally Advanced Pancreatic Cancer
Lead sponsor
Soroka University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2011
Completion date
July 31, 2015
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer